Chief, Experimental Transplantation and Immunology Branch, CCR, NCI, NIH
Oncology
Dr. Ronald E. Gress, MD
|
|
Give Review
Ronald E. Gress is an expert in the field of Oncology. He researched medicine at Baylor College of Medicine. He received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Doctor Ronald E. Gress, MD is a published physician as well. He has 69 publications published. The latest was: Oral Disease Profiles in Chronic Graft versus Host Disease.
Publications
- Oral Disease Profiles in Chronic Graft versus Host Disease.
- NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.
- Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity.
- Malnutrition in patients with chronic GVHD.
- Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.
- Thymic Medullary Epithelium and Thymocyte Self-Tolerance Require Cooperation between CD28-CD80/86 and CD40-CD40L Costimulatory Pathways.
- NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
- Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.
- Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
- Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.
- Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Trans...
- B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma.
- Sensitive GC-MS/MS Method to Measure Deuterium Labeled Deoxyadenosine in DNA from Limited Mouse Cell Populations.
- Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
- National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators o...
- Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.
- The aging immune system and its relationship with cancer.
- Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.
- Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer.
- Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
- Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells.
- Tbata modulates thymic stromal cell proliferation and thymus function.
- The thymus and the immune system: layered levels of control.
- Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells.
- Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for...
- Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.
- Immune reconstitution: how it should work, what's broken, and why it matters.
- Perspective on potential clinical applications of recombinant human interleukin-7.
- Reduced thymus activity and infection prematurely age the immune system.
- Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury.
- Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.
- Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international ...
- Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.
- Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.
- Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation.
- CCL25 increases thymopoiesis after androgen withdrawal.
- Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion.
- Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.
- Murine models of chronic graft-versus-host disease: insights and unresolved issues.
- Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associa...
- Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation.
- Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides.
- Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeos...
- Lymphoid reconstruction and vaccines.
- Thymic involution: implications for self-tolerance.
- Interleukin-7 immunotherapy.
- Synergism between CpG-containing oligodeoxynucleotides and IL-2 causes dramatic enhancement of vaccine-elicited CD8+ T cell responses.
- Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
- Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice.
- IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.
- B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells.
- Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma.
- Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface.
- Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast canc...
- TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
- Age-dependent incidence, time course, and consequences of thymic renewal in adults.
- Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
- Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis.
- L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
- Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution.
- Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis.
- A dose effect of IL-7 on thymocyte development.
- Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function.
- Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.
- Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells.
- Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
- Proliferation kinetics of subpopulations of human marrow cells determined by quantifying in vivo incorporation of [2H2]-glucose into DNA of S-phase cells.
- Reconstitution of thymic function after stem cell transplantation in humans.
Schools
Baylor University
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Baylor College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Richard Piekarz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kieron M. Dunleavy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard L. Parnes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey S. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Gulley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lee J. Helman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Lechleider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. C N. Coleman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Binder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel Broder, MD
This Doctor is OpenDoctor Recommended.
|